NantHealth Statistics
Total Valuation
NantHealth has a market cap or net worth of $16.48 million. The enterprise value is $285.04 million.
| Market Cap | 16.48M |
| Enterprise Value | 285.04M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NantHealth has 27.47 million shares outstanding. The number of shares has increased by 94.84% in one year.
| Shares Outstanding | 27.47M |
| Shares Change (YoY) | +94.84% |
| Shares Change (QoQ) | +94.84% |
| Owned by Insiders (%) | 88.31% |
| Owned by Institutions (%) | 4.33% |
| Float | 7.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -44.50% |
| Return on Capital (ROIC) | -183.59% |
| Revenue Per Employee | $176,088 |
| Profits Per Employee | -$192,803 |
| Employee Count | 365 |
| Asset Turnover | 0.41 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -264,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 1.51, so NantHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 23.19 |
| Average Volume (20 Days) | 391 |
Short Selling Information
The latest short interest is 37,953, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 37,953 |
| Short Previous Month | 44,921 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.54% |
| Short Ratio (days to cover) | 6.13 |
Income Statement
In the last 12 months, NantHealth had revenue of $64.27 million and -$70.37 million in losses. Loss per share was -$8.26.
| Revenue | 64.27M |
| Gross Profit | 39.35M |
| Operating Income | -44.44M |
| Pretax Income | -70.64M |
| Net Income | -70.37M |
| EBITDA | -39.28M |
| EBIT | -53.13M |
| Loss Per Share | -$8.26 |
Balance Sheet
The company has $5.82 million in cash and $274.38 million in debt, giving a net cash position of -$268.56 million or -$9.78 per share.
| Cash & Cash Equivalents | 5.82M |
| Total Debt | 274.38M |
| Net Cash | -268.56M |
| Net Cash Per Share | -$9.78 |
| Equity (Book Value) | -250.18M |
| Book Value Per Share | -9.11 |
| Working Capital | -175.76M |
Cash Flow
In the last 12 months, operating cash flow was -$27.64 million and capital expenditures -$4.38 million, giving a free cash flow of -$32.02 million.
| Operating Cash Flow | -27.64M |
| Capital Expenditures | -4.38M |
| Free Cash Flow | -32.02M |
| FCF Per Share | -$2.13 |
Margins
Gross margin is 61.22%, with operating and profit margins of -69.14% and -109.49%.
| Gross Margin | 61.22% |
| Operating Margin | -69.14% |
| Pretax Margin | -109.90% |
| Profit Margin | -109.49% |
| EBITDA Margin | -61.12% |
| EBIT Margin | -82.66% |
| FCF Margin | -49.81% |
Dividends & Yields
NantHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.84% |
| Shareholder Yield | -94.84% |
| Earnings Yield | -426.95% |
| FCF Yield | -194.25% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 16, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Dec 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NantHealth has an Altman Z-Score of -13.31 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.31 |
| Piotroski F-Score | 4 |